(Morning Ticker) – Recently we reported on the FDA’s decision to approve Entresto, a new drug from Novartis that has shown an astonishing 20 percent reduction in mortality and hospitalization […]
(Morning Ticker) – Recently we reported on the FDA’s decision to approve Entresto, a new drug from Novartis that has shown an astonishing 20 percent reduction in mortality and hospitalization […]